Home
About
Overview
Sharing Data
ORCID
Help
History (42)
c-FLIP efficiently rescues TRAF-2-/- cells from TNF-induced apoptosis.
5,7-Dihydroxytryptamine
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.
Spectrum of gross motor function in extremely low birth weight children with cerebral palsy at 18 months of age.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
See All 42 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med. 2010 Jun 17; 362(24):2251-9.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzamides
Blast Crisis
Disease Progression
Female
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Kaplan-Meier Estimate
Leukemia, Myeloid, Chronic-Phase
Male
Middle Aged
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Young Adult
authors with profiles
Richard A. Larson